The randomized, multicenter, controlled clinic trail for treating advanced non-small cell lung cancer with combined traditional chinese medicine and vinorelbine (Navelbine, NVB) plus cisplatin (DDP) chemotherapy

The randomized, multicenter, controlled clinic trail for treating advanced non-small cell lung cancer with combined traditional chinese medicine and vinorelbine (Navelbine, NVB) plus cisplatin (DDP) chemotherapy

Bibliographic Details
Main Authors:	Yanzhi CHEN, Lijun DI, Shulan ZHANG, Maosen CHEN, Hong SUN, Fei GAO, Ying ZHANG, Pingping LI
Format:	Article
Language:	zho
Published:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2008-06-01
Series:	Chinese Journal of Lung Cancer
Subjects:	Lung neoplasms
Online Access:	http://www.lungca.org/index.php?journal=01&page=article&op=view&path[]=10.3779%2Fj.issn.1009-3419.2008.03.003&path[]=98

Similar Items

A Randomized Trial of NVB plus DDP with Versus without Thalidomide in the Treatment of Advanced Non Small Cell Lung Cancer
by: Xiaoling ZHANG, et al.
Published: (2008-04-01)

The Effect and Mechanism of Vinorelbine on Cisplatin Resistance  of Human Lung Cancer Cell Line A549/DDP
by: Chunsheng QI, et al.
Published: (2014-02-01)

Vinorelbine plus Oxaliplatin versus Vinorelbine plus Cisplatin for Advanced Non-small Cell Lung Cancer: A Systematic Review
by: Kehu YANG, et al.
Published: (2010-02-01)

Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma
by: Toshirou Fukushima, et al.
Published: (2014-01-01)

Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients
by: Ma Jing-Jing, et al.
Published: (2010-06-01)

Idiopathic hyperammonemia after chemotherapy with vinorelbine, topotecan, and cisplatin in a patient with acute lymphocytic leukemia
by: Yu-Hsien Chen, et al.
Published: (2010-10-01)

Comparison between Vinorelbine–Carboplatin and Vinorelbine–Cisplatin in Stage III–IV EGFR Mutations-Negative NSCLC
by: Laksmi Wulandari, et al.
Published: (2021-08-01)

Gemcitabine, Navelbine, and Doxorubicin as Treatment for Patients with Refractory or Relapsed T-Cell Lymphoma
by: Zhengzi Qian, et al.
Published: (2015-01-01)

Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)
by: Nikaedo Sueli M, et al.
Published: (2004-09-01)

Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI
by: Katrina M. Ingley, et al.
Published: (2019-09-01)

Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol
by: Dienemann Hendrik, et al.
Published: (2007-05-01)

MODERN POSSIBILITIES OF APPLICATION OF PREPARATION NAVELBINE® IN THE TREATMENT OF METASTATIC BREAST CANCER
by: L. V. Bolotina
Published: (2016-06-01)

Comparison of Gemcitabine Plus Cisplatin vs. Docetaxel Plus Fluorouracil Plus Cisplatin Palliative Chemotherapy for Metastatic Nasopharyngeal Carcinoma
by: Xue-Song Sun, et al.
Published: (2020-08-01)

Comparison of Vinorelbine-Cisplatin with Gemcitabine-Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer
by: Sevket Ozkaya, et al.
Published: (2008-01-01)

Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway
by: Wu S, et al.
Published: (2016-10-01)

Expression and significance of clusterin in Anip973/NVB cell lines
by: Wei LIU, et al.
Published: (2008-10-01)

Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine in Patients With Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Retrospective Study
by: Yizhao Xie, et al.
Published: (2021-08-01)

Improved compliance with adjuvant vinorelbine and cisplatin in non-small cell lung cancer
by: Ali Aljubran, et al.
Published: (2009-01-01)

The Reversing and Molecular Mechanisms of miR-503 on the Drug-resistance  to Cisplatin in A549/DDP Cells
by: Yi WU, et al.
Published: (2014-01-01)

Giant cell carcinoma of the lung successfully treated with surgical resection and adjuvant vinorelbine and cisplatin
by: Saad Habib, et al.
Published: (2018-01-01)

J. Bank, Opkomst en ondergang van de Nederlandse Volksbeweging (NVB)
by: J.L.J. Bosmans
Published: (1980-01-01)

J. Bank, Opkomst en ondergang van de Nederlandse Volksbeweging (NVB)
by: J.L.J. Bosmans
Published: (1980-01-01)

J. Bank, Opkomst en ondergang van de Nederlandse Volksbeweging (NVB)
by: J.L.J. Bosmans
Published: (1980-01-01)

Oral vinorelbine plus cisplatin with concomitant radiotherapy as induction therapy for stage III non‐small cell lung cancer: Results of a single‐arm prospective cohort study
by: Ping‐Chih Hsu, et al.
Published: (2019-08-01)

Asiatic Acid (AA) Sensitizes Multidrug-Resistant Human Lung Adenocarcinoma A549/DDP Cells to Cisplatin (DDP) via Downregulation of P-Glycoprotein (MDR1) and Its Targets
by: Qilai Cheng, et al.
Published: (2018-05-01)

Effects of Pachyman in Combination with Vinorelbine and Cisplatin on Tumor Growth and the Expression of EGFR and K-ras in Mice with Lung Cancer
by: Ke WEI, et al.
Published: (2018-12-01)

The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells
by: Ling-Yun Ye, et al.
Published: (2017-03-01)

Synergistic Antitumor Effect of Amorphigenin Combined with Cisplatin in Human Lung Adenocarcinoma A549/DDP Cells
by: Hongzhen ZHONG, et al.
Published: (2016-12-01)

NMR studies of the relationship between the changes of membrane lipids and the cisplatin-resistance of A549/DDP cells
by: Huang Youguo, et al.
Published: (2003-04-01)

Expression and Significance of IKBKB in Pulmonary Adenocarcinoma A549 Cells and Its Cisplatin-resistant Variant A549/DDP
by: Kang QI, et al.
Published: (2014-05-01)

Assessment on the Efficacy and Safety of Aidi Injection Combined with Vinorelbine and Cisplatin for Treatment of Advanced Nonsmall Cell Lung Cancer
by: Hua-Ye Zhao, et al.
Published: (2016-01-01)

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
by: Zhen Zeng, et al.
Published: (2018-10-01)

On Finding the Right Sampling Line Height through a Parametric Study of Gas Dispersion in a NVB
by: E. Moustapha Doumbia, et al.
Published: (2021-05-01)

Shenmai Injection Supresses Glycolysis and Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant A549/DDP Cells via the AKT-mTOR-c-Myc Signaling Pathway
by: Ye Sun, et al.
Published: (2020-01-01)

The reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cells
by: Zhi Jiang, et al.
Published: (2009-04-01)

Reinduction of Hormone Sensitivity to Goserelin following Chemotherapy with Vinorelbine in Castration-Resistant Prostate Cancer
by: Tal Grenader, et al.
Published: (2010-01-01)

Neoadjuvant Combination Chemotherapy with Pegylated Liposomal Doxorubicin and Vinorelbine for Locally Advanced Breast Cancer
by: Zhen-zhou SHEN, et al.
Published: (2010-02-01)

A Retrospective Analysis of Vinorelbine Chemotherapy for Patients With Previously Treated Soft-Tissue Sarcomas
by: Sibyl E. Anderson, et al.
Published: (2006-01-01)

A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study
by: Pizzuti Laura, et al.
Published: (2011-04-01)

Pyrotinib Combined With Vinorelbine in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study
by: Yi Li, et al.
Published: (2021-04-01)